The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Activation of Lipoxin a4 Receptors by Aspirin-Triggered Lipoxins and Select Peptides Evokes Ligand-Specific Responses in Inflammation
Open accessAbstract
Lipoxin (LX) A4 and aspirin-triggered LX (ATL) are endogenous lipids that regulate leukocyte trafficking via specific LXA4 receptors (ALXRs) and mediate antiinflammation and resolution. ATL analogues dramatically inhibited human neutrophil (polymorphonuclear leukocyte [PMN]) responses evoked by a potent necrotactic peptide derived from mitochondria as well as a rogue synthetic chemotactic peptide. These bioactive lipid analogues and small peptides each selectively competed for specific 3H-LXA4 binding with recombinant human ALXR, and its N-glycosylation proved essential for peptide but not LXA4 recognition. Chimeric receptors constructed from receptors with opposing functions, namely ALXR and leukotriene B4 receptors (BLTs), revealed that the seventh transmembrane segment and adjacent regions of ALXR are essential for LXA4 recognition, and additional regions of ALXR are required for high affinity binding of the peptide ligands. Together, these findings are the first to indicate that a single seven-transmembrane receptor can switch recognition as well as function with certain chemotactic peptides to inhibitory with ATL and LX (lipid ligands). Moreover, they suggest that ALXR activation by LX or ATL can protect the host from potentially deleterious PMN responses associated with innate immunity as well as direct effector responses in tissue injury by recognition of peptide fragments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Acute-Phase Proteins and Other Systemic Responses to Inflammation
Gabay, C., & Kushner, I. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902113400607 · Cited by 6,734 · cited 3×
“Of interest, SAA levels in peripheral blood are increased as much as 1,000-fold during inflammatory disorders (30), and SAA, given its hydrophobicity, associates with high density lipoproteins when levels exceed 1,000-fold basal values (41).”
BackgroundAnti-inflammatory Properties of Cytochrome P450 Epoxygenase-Derived Eicosanoids
Node, K., Huo, Y., Ruan, X., Yang, B., Spiecker, M., Ley, K., Zeldin, D. C., & Liao, J. K. (1999) · Science · doi:10.1126/science.285.5431.1276 · Cited by 1,215
Immune System Impairment and Hepatic Fibrosis in Mice Lacking the Dioxin-Binding Ah Receptor
Fernandez-Salguero, P., Pineau, T., Hilbert, D. M., McPhail, T., Lee, S. S. T., Kimura, S., Nebert, D. W., Rudikoff, S., Ward, J. M., & Gonzalez, F. J. (1995) · Science · doi:10.1126/science.7732381 · Cited by 1,075
Recognition of a lipid antigen by CD1-restricted αβ+ T cells
Beckman, E. M., Porcelli, S. A., Morita, C. T., Behar, S. M., Furlong, S. T., & Brenner, M. B. (1994) · Nature · doi:10.1038/372691a0 · Cited by 978
A G-protein-coupled receptor for leukotriene B4 that mediates chemotaxis
Yokomizo, T., Izumi, T., Chang, K., Takuwa, Y., & Shimizu, T. (1997) · Nature · doi:10.1038/42506 · Cited by 971
A 48-well micro chemotaxis assembly for rapid and accurate measurement of leukocyte migration
Falk, W., Goodwin, R. H., & Leonard, E. J. (1980) · Journal of Immunological Methods · doi:10.1016/0022-1759(80)90211-2 · Cited by 941
Release of Inflammatory Mediators from Stimulated Neutrophils
Bleich, H. L., Moore, M. J., Weissmann, G., Smolen, J. E., & Korchak, H. M. (1980) · New England Journal of Medicine · doi:10.1056/nejm198007033030109 · Cited by 654
Inflammation: Basic Principles and Clinical Correlates
Ehrlich, G. E. (2000) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.283.1.123 · Cited by 622
Identification of a human cDNA encoding a functional high affinity lipoxin A4 receptor.
Fiore, S., Maddox, J. F., Perez, H. D., & Serhan, C. N. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.1.253 · Cited by 436
Self-citationTakano, T., Fiore, S., Maddox, J. F., Brady, H. R., Petasis, N. A., & Serhan, C. N. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.9.1693 · Cited by 431
Self-citationSu, S. B., Gong, W., Gao, J.-L., Shen, W., Murphy, P. M., Oppenheim, J. J., & Wang, J. M. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.2.395 · Cited by 429
Lipid mediator networks in cell signaling: update and impact of cytokines 1
Serhan, C. N., Haeggström, J. Z., & Leslie, C. C. (1996) · The FASEB Journal · doi:10.1096/fasebj.10.10.8751717 · Cited by 394
Self-citationDesign of Lipoxin A4 Stable Analogs That Block Transmigration and Adhesion of Human Neutrophils
Serhan, C. N., Maddox, J. F., Petasis, N. A., Akritopoulou-Zanze, I., Papayianni, A., Brady, H. R., Colgan, S. P., & Madara, J. L. (1995) · Biochemistry · doi:10.1021/bi00044a041 · Cited by 327
Self-citationLipoxin biosynthesis and its impact in inflammatory and vascular events
Serhan, C. N. (1994) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(94)90185-6 · Cited by 273
Self-citationMaddox, J. F., Hachicha, M., Takano, T., Petasis, N. A., Fokin, V. V., & Serhan, C. N. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.11.6972 · Cited by 266
Self-citationLipoxin A4: A New Class of Ligand for the Ah Receptor
Schaldach, C. M., Riby, J., & Bjeldanes, L. F. (1999) · Biochemistry · doi:10.1021/bi982861e · Cited by 264
Peptide Binding and Presentation by Mouse CD1
Castaño, A. R., Tangri, S., Miller, J. E. W., Holcombe, H. R., Jackson, M. R., Huse, W. D., Kronenberg, M., & Peterson, P. A. (1995) · Science · doi:10.1126/science.7542403 · Cited by 244
Tessier, P. A., Naccache, P. H., Clark-Lewis, I., Gladue, R. P., Neote, K. S., & McColl, S. R. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.7.3595 · Cited by 233
Weissmann, G. (1991) · Scientific American · doi:10.1038/scientificamerican0191-84 · Cited by 229
Chiang, N., Gronert, K., Clish, C. B., O’Brien, J. A., Freeman, M. W., & Serhan, C. N. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7016 · Cited by 218
Self-citationClish, C. B., O’Brien, J. A., Gronert, K., Stahl, G. L., Petasis, N. A., & Serhan, C. N. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.14.8247 · Cited by 212
Self-citationHachicha, M., Pouliot, M., Petasis, N. A., & Serhan, C. N. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.12.1923 · Cited by 199
Self-citationTHE NEUTROPHIL IN RHEUMATOID ARTHRITIS
Pillinger, M. H., & Abramson, S. B. (1995) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(21)00463-4 · Cited by 182
Brimhall, G. H. (1991) · Scientific American · doi:10.1038/scientificamerican0591-84 · Cited by 156
Nonclassical binding of formylated peptide in crystal structure of the MHC class lb molecule H2-M3
Wang, C.-R., Castaño, A. R., Peterson, P. A., Slaughter, C. A., Lindahl, K. F., & Deisenhofer, J. (1995) · Cell · doi:10.1016/0092-8674(95)90037-3 · Cited by 151
Identification of surrogate agonists for the human FPRL-1 receptor by autocrine selection in yeast
Klein, C., Paul, J. I., Sauvé, K., Schmidt, M. M., Arcangeli, L., Ransom, J. T., Trueheart, J., Manfredi, J. P., Broach, J. R., & Murphy, A. J. (1998) · Nature Biotechnology · doi:10.1038/4310 · Cited by 150
Munger, K. A., Montero, A., Fukunaga, M., Uda, S., Yura, T., Imai, E., Kaneda, Y., Valdivielso, J. M., & Badr, K. F. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.23.13375 · Cited by 148
Lipoxin recognition sites. Specific binding of labeled lipoxin A4 with human neutrophils.
Fiore, S., Ryeom, S. W., Weller, P. F., & Serhan, C. N. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)41982-5 · Cited by 139
Self-citationSamuelsson, B. O. (1983) · Bioscience Reports · doi:10.1007/bf01133779 · Cited by 129
Quehenberger, O., Prossnitz, E. R., Cavanagh, S. L., Cochrane, C. G., & Ye, R. D. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)46825-6 · Cited by 122
LINKE, R. P., Bock, V., Valet, G., & Rothe, G. (1991) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(91)90397-p · Cited by 122
Deng, X., Ueda, H., Su, S. B., Gong, W., Dunlop, N. M., Gao, J., Murphy, P. M., & Wang, J. (1999) · Blood · doi:10.1182/blood.v94.4.1165 · Cited by 121
Fiore, S., & Serhan, C. N. (1995) · Biochemistry · doi:10.1021/bi00051a016 · Cited by 118
Self-citationCytosolic Free Calcium and the Cytoskeleton in the Control of Leukocyte Chemotaxis
Pettit, E. J., & Fay, F. S. (1998) · Physiological Reviews · doi:10.1152/physrev.1998.78.4.949 · Cited by 107
Recombinant human serum amyloid A (apoSAAp) binds cholesterol and modulates cholesterol flux
Liang, J.-S., & Sipe, J. D. (1995) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39752-2 · Cited by 105
Levy, B. D., Fokin, V. V., Clark, J. M., Wakelam, M. J. O., Petasis, N. A., & Serhan, C. N. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.8.903 · Cited by 101
Self-citationAspirin as Prophylaxis against Colorectal Cancer
Marcus, A. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199509073331011 · Cited by 82
Les Prix Nobel : Nobel Prizes, presentations, biographies and lectures
Nobelstiftelsen (1982) · Almqvist & Wiksell International eBooks · Cited by 70
Regulation of Leukocyte Trafficking by Lipoxins
Diamond, P., McGinty, A., SUGRUE, D. D., Brady, H. R., & Godson, C. (1999) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.1999.051 · Cited by 34
Shawar, S. M., Rich, R. R., & Becker, E. L. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.1884 · Cited by 33
Identification of anN-Formyl Peptide Receptor Ligand Binding Domain by a Gain-of-Function Approach
Quehenberger, O., Pan, Z. K., Prossnitz, E. R., Cavanagh, S. L., Cochrane, C. G., & Ye, R. D. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7298 · Cited by 30
Gronert, K., Colgan, S. P., & Serhan, C. N. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37404-x · Cited by 27
Self-citationStructure and Function of Prostanoid Receptors as Revealed by Site-Directed Mutagenesis
Tai, H., Huang, C. B., & Chiang, N. (1997) · Advances in experimental medicine and biology · doi:10.1007/978-1-4899-1813-0_31 · Cited by 6
Self-citation
Cited by
Arita, M., Bianchini, F., Aliberti, J., Sher, A., Chiang, N., Hong, S., Yang, R., Petasis, N. A., & Serhan, C. N. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20042031 · Cited by 922
Self-citationYe, R. D., Boulay, F., Wang, J. M., Dahlgren, C., Gerard, C., Parmentier, M., Serhan, C. N., & Murphy, P. M. (2009) · Pharmacological Reviews · doi:10.1124/pr.109.001578 · Cited by 764
Self-citationResolvin D1 binds human phagocytes with evidence for proresolving receptors
Krishnamoorthy, S., Recchiuti, A., Chiang, N., Yacoubian, S., Lee, C.-H., Yang, R., Petasis, N. A., & Serhan, C. N. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0907342107 · Cited by 730
Self-citationFormyl-peptide receptors revisited
LE, Y., MURPHY, P., & WANG, J. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02316-5 · Cited by 597
The Concise Guide to PHARMACOLOGY 2013/14: G Protein‐Coupled Receptors
Alexander, S. P. H., Benson, H. E., Faccenda, E., Pawson, A. J., Sharman, J. L., Spedding, M., Peters, J. A., Harmar, A. J., & Collaborators, C. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12445 · Cited by 556
Metadata
- Authors
- Chiang, N., Fierro, I. M., Gronert, K., & Serhan, C. N.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2000-04-03
- Volume
- 191
- Issue
- 7
- Pages
- 1197-1208
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2139357620
- Cited by
- 260
- References
- 43
- FWCI
- 14.94
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.